Growth Metrics

GoodRx Holdings (GDRX) Amortization of Deferred Charges (2019 - 2026)

GoodRx Holdings' Amortization of Deferred Charges history spans 7 years, with the latest figure at $454000.0 for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges rose 7.84% to $454000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 29.2% decrease, with the full-year FY2025 number at $1.8 million, down 29.2% from a year prior.
  • Amortization of Deferred Charges hit $454000.0 in Q4 2025 for GoodRx Holdings, up from $445000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for GDRX hit a ceiling of $864000.0 in Q2 2021 and a floor of $413000.0 in Q3 2024.
  • Historically, Amortization of Deferred Charges has averaged $725250.0 across 5 years, with a median of $845000.0 in 2023.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 50.7% in 2021 and later crashed 51.07% in 2024.
  • Tracing GDRX's Amortization of Deferred Charges over 5 years: stood at $859000.0 in 2021, then decreased by 0.93% to $851000.0 in 2022, then fell by 0.94% to $843000.0 in 2023, then tumbled by 50.06% to $421000.0 in 2024, then grew by 7.84% to $454000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for GDRX at $454000.0 in Q4 2025, $445000.0 in Q3 2025, and $439000.0 in Q2 2025.